Generon (Shanghai) Corporation Ltd. Initiates a Phase II Clinical Trial for F-627 after US FDA Clearance – StreetInsider.com

Generon (Shanghai) Corporation Ltd.Feng Li, Vice President Business DevelopmentTel: +86 21 5132-0626 x 8029Fax: +86 21 5132-0623Email: LiFeng@generonbiomed.comWebsite: www.generonbiomed.com